Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Cerevel Therapeutics Inc...

    NASDAQ: CERE · Real-Time Price · USD
    44.96
    0.33 (0.74%)
    At close: Jul 31, 2024, 10:00 PM

    Cerevel Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -432.84M -351.51M -225.33M
    Depreciation & Amortization
    		 5.63M 4.9M 2.73M
    Stock-Based Compensation
    		 69.41M 38.78M 23.94M
    Other Working Capital
    		 14.07M 28.83M 8.26M
    Other Non-Cash Items
    		 1.43M -13.42M 694K
    Deferred Income Tax
    		 -2.04M n/a 3.88M
    Change in Working Capital
    		 16.11M 28.06M 15.54M
    Operating Cash Flow
    		 -342.3M -293.19M -178.55M
    Capital Expenditures
    		 -3.81M -3.95M -10.5M
    Cash Acquisitions
    		 -77.53K 384.88K n/a
    Purchase of Investments
    		 -865.27M -887.74M -425.16M
    Sales Maturities Of Investments
    		 942.8M 502.86M n/a
    Other Investing Acitivies
    		 77.53K -384.88K -425.16K
    Investing Cash Flow
    		 73.72M -388.83M -435.66M
    Debt Repayment
    		 n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 548.62M 623.19M 423.6M
    Financial Cash Flow
    		 548.62M 623.19M 423.6M
    Net Cash Flow
    		 98.94M -58.83M -190.6M
    Free Cash Flow
    		 -346.11M -297.14M -189.05M

    Add to Watchlist